Skip to the page

Data / Form D filings / BiomeSense, Inc.

BiomeSense, Inc.: Form D filings

BiomeSense, Inc., a biotechnology company in Chicago, IL, filed 3 Form D notices with the SEC between 2019 and 2025. The latest, on November 3, 2025, reports $7.1 million sold of a $7.3 million offering to 27 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
2242 W. HARRISON ST, STE 201, Chicago, IL, 60612
Phone
(847) 471-8663
Industry
Biotechnology
Entity type
Corporation
Incorporated in
Delaware
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1789915

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Nov 3, 2025New notice$7,250,000$7,059,599$190,40127Jul 18, 2025sec.gov
Dec 19, 2023New notice$6,523,999$6,178,594$345,40533Feb 14, 2023sec.gov
Oct 2, 2019New notice$2,499,999$2,424,996$75,0035Sep 17, 2019sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Dylan NicholsDirector
Ashley HartmanDirector
Kevin HonakerExecutive Officer, Director
Vanessa Rollings GiannisDirector
Andrew BluesteinDirector

Other biotechnology companies in Illinois that filed recently

Every Form D from the week of Nov 3, 2025 · All recent filings in Illinois · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what BiomeSense, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.